Strategic R&D Ally EBI is a focused R&D center under Hengrui Medicine, located in Cranbury, NJ, targeting oncology and immunology. This presents an opportunity for BD outreach to supply early-stage research tools, screening libraries, and collaboration in target validation to accelerate preclinical programs.

Small Team, Big Needs With a small team (2-10 employees) and rapid translation from target discovery to lead optimization, EBI may benefit from scalable internal collaboration platforms, outsourced CRO partnerships, and modular analytical services to augment capacity without a large in-house expansion.

Big Parent, Global Scope As the NJ R&D arm of a top-30 global pharma with a vast network and substantial funding, there is potential to position as a preferred vendor for ancillary services, contract research, and co-development activities leveraging Hengrui’s international footprint.

Tech Stack Fit EBI’s use of common web and data technologies suggests openness to modern cloud-based data management, analytics, and collaboration tools. Propose integrated biomolecular data platforms, AI-enabled lead optimization, and secure data exchange to streamline joint projects.

Portfolio Synergy EBI focuses on oncology and immunology with a mission to deliver first-in-class or best-in-class candidates. Align outreach with translational services, medicinal chemistry, structure-guided design packages, and early-access to novel screening libraries to support their discovery pipeline.